The moment doula care became investable
As Medicaid expands coverage and outcomes become measurable, a once-marginal support role is emerging as a scalable, payer-backed care model
So much of pregnancy care happens between appointments.
When a woman leaves a prenatal check-up, she often has questions - about symptoms, nutrition, or what comes next. That space between appointments is where risk can build, and where traditional healthcare models have historically had little visibility.
This is where doulas step in - providing continuity, guidance and support outside of clinical settings. And increasingly, that support is being linked to improved maternal health outcomes.
But doulas are not new.
So why is capital showing up now?
A sudden wave of funding
Over the past week or so, three US-based maternal health startups have raised nearly $27 million between them.
Nadia Care (formerly Cayaba Care) secured $12 million with the round led by Valtruis alongside a major national payer too — a notable signal that insurers are not just observing these models, but actively backing them. The company is expanding its hybrid model of in-home and virtual maternal support across Washington DC, Maryland and Tennessee.
Days earlier, Malama launched with $9.2 million in seed funding to scale a doula-led model combining remote monitoring, care navigation and postpartum support.
And this week, Flourish Care - a maternal healthcare platform building a nationwide doula network - has raised $5.7 million in seed funding to scale its model across the US.
All three centre the role of the doula — non-clinical professionals providing continuous emotional, practical and informational support during pregnancy and after birth — within broader, coordinated care models.
At first glance, this looks like a moment for doulas. In reality, it’s a shift in what makes a care model investable.
The policy unlock
For most of its history, doula care has been difficult to scale.
It sat outside the formal healthcare system — largely paid out-of-pocket, and therefore inaccessible to many of the populations who could benefit most.
That is now changing.
In 2018, only Minnesota and Oregon offered Medicaid coverage for doula care. By 2024, 14 states and Washington DC had introduced coverage. Today, more than 30 states offer some form of reimbursement, though implementation varies.
This matters because Medicaid covers around 40% of births in the US.
For the first time, doula care has a payer, a reimbursement pathway and a route into formal care delivery. Together that changes the economics.
From support service to scalable model
At the same time, the model itself has evolved. These companies are building structured systems around doulas combining care navigation, remote monitoring, postpartum support, data collection on outcomes.
We’re also seeing this shift reflected more broadly across the market.
Maven has been one of the most prominent advocates, publishing peer-reviewed research on virtual doula care in 2024. Progyny added doula services to employer health plans in 2025, and Pomelo Care acquired The Doula Network in 2024, expanding access to more than 15 million lives.
Doulas are no longer operating at the margins. They are being integrated into care pathways.
Why this matters to investors
Maternal health in the US is both high-cost and underperforming. Outcomes remain among the worst in high-income countries, with disparities particularly acute among Medicaid populations.
At the same time, care is still largely organised around short clinical appointments - often missing the day-to-day realities that shape maternal health, from transportation and nutrition to mental health and housing stability.
This creates a gap and increasingly, that gap is measurable.
Early data from companies like Nadia Care and Malama suggests improvements in outcomes such as preterm birth, NICU utilisation and emergency care. This is also supported by a growing body of research, particularly for higher-risk groups.
For investors, that shift is critical. Because these are not just clinical improvements - they are cost drivers. Reducing preterm births or NICU stays has a direct economic impact for payers. And when those outcomes can be improved through a lower-cost, non-clinical workforce, the model becomes significantly more attractive.
The involvement of a national payer in Nadia Care’s round is particularly significant. It suggests that the organisations ultimately responsible for maternal care costs are not just willing to reimburse these models - but to invest in them directly. That alignment between outcomes, cost reduction and payer incentives is what turns a model like this from promising to investable. This is no longer just venture capital placing bets on new care models - it is payers beginning to reshape how maternal care is delivered.
What happens next
If this trend continues, doula-led models are unlikely to remain a standalone category. Instead, they point to a broader shift in maternal health - toward models that extend beyond clinical settings and focus on continuous, prevention-oriented care.
That shift is also beginning to show up in how maternity care is paid for. In the US, the American Medical Association has announced plans to retire the long-standing bundled maternity payment model from 2027, replacing it with itemised billing across prenatal, delivery and postpartum care.
On the surface, this is a technical change but in practice, it could be significant. The previous bundled model paid a single fee for pregnancy and birth, often leaving postpartum care underdelivered and financially invisible. Moving to itemised payments creates clearer reimbursement pathways for services that sit outside traditional clinical encounters - including ongoing support, remote monitoring and more specialised interventions.
In that context, models built around continuous support - including doula-led care - become easier to integrate, measure and fund.
Doulas may be the starting point. But the real signal is that maternal care is beginning to shift toward a more modular, continuous system - one that can accommodate a wider range of providers beyond the traditional clinical model.